Overview

Low and High Dose Zonisamide in Children as Monotherapy

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the adjustment dosage of zonisamide as monotherapy in children with epilepsy.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Korea Inc.
Treatments:
Zonisamide